M003

R-(−)-Deprenyl hydrochloride

≥98% (HPLC), MAO-B inhibitor, powder

• Sinonimo/i: (R)-(−)-N,α-Dimethyl-N-(2-propynyl)phenethylamine hydrochloride, R(−)-N-α-Dimethyl-N-2-propynyl-benzeneethanamine hydrochloride, Selegiline hydrochloride
• Formula empirica (notazione di Hill): C₁₃H₁₇N · HCl
• Numero CAS: 14611-52-0
• Peso molecolare: 223.74
• UNSPSC Code: 12352200
• PubChem Substance ID: 24278577
• NACRES: NA.77
• MDL number: MFCD00069299
• Assay: ≥98% (HPLC)
• Form: powder

Proprietà

• Nome del prodotto: R-(−)-Deprenyl hydrochloride, powder, ≥98% (HPLC)
• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• optical activity: [α]25/D −10.8°, c = 6.48 in H₂O(lit.)
• color: white
• mp: 141-142 °C
• solubility: H₂O: >10 mg/mL
• originator: Sanofi Aventis
• SMILES string: Cl[H].C[C@H](Cc1ccccc1)N(C)CC#C
• InChI: 1S/C13H17N.ClH/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13;/h1,5-9,12H,10-11H2,2-3H3;1H/t12-;/m1./s1
• InChI key: IYETZZCWLLUHIJ-UTONKHPSSA-N
• Gene Information: human ... MAOB(4129)

Descrizione

Biochem/physiol Actions

Selective MAO-B inhibitor; anti-Parkinsonian agent.

Features and Benefits

This compound is featured on the Dopamine and Norepinephrine Metabolism and Histamine Synthesis and Metabolism pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Informazioni sulla sicurezza

• pictograms: GHS07
• signalword: Warning
• hcodes: H302,H336
• pcodes: P301 + P312 + P330
• Hazard Classifications: Acute Tox. 4 Oral - STOT SE 3
• target_organs: Central nervous system
• Classe di stoccaggio: 11 - Combustible Solids
• wgk: WGK 1
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)